Cancer Immunotherapy Winter School

Jan. 13–17, 2020 • Houston

View Enduring Materials 

The Society for Immunotherapy of Cancer (SITC) was pleased to host its second Cancer Immunotherapy Winter School, a comprehensive cancer immunotherapy education program, on Jan. 13–17, 2020, at the Hilton Houston Post Oak in Houston. Taught by leading experts in the field, this five-day program provided attendees with a deep understanding of the core principles of tumor immunology and cancer immunotherapy and examined developing areas in the field.

The Cancer Immunotherapy Winter School, is tailored to early-to-mid career scientists and clinicians in the field of cancer immunotherapy working in academic, clinical, industry and government settings as well as those new to the field. The curriculum covers the fundamentals of cancer immunotherapy and features separate tracks, clinical and research, allowing participants to tailor their experience by selecting the educational path most relevant to their learning goals.

During the program, participants learn:

• Core principles of tumor immunology and cancer immunotherapy
• Recent advancements in drug and biomarker technologies and their clinical application
• Best practices in clinical trial design and appropriate clinical trial data analysis methods

In addition to deepening their understanding of integral facets of the field of cancer immunotherapy, attendees also expand their professional network, developing new relationships with faculty and other thought leaders in this intimate setting through small group breakout sessions and networking roundtables.

This program was supported in part by grants from AbbVie, AstraZeneca Pharmaceuticals LP, Celgene Corporation, Exelixis, Inc., Merck & Co., Inc. and Pfizer, Inc. (as of January 17^th, 2020). 

Cancer Immunotherapy Winter School Target Audience

• Early-to-mid career scientists in the field of cancer immunotherapy working in academic, clinical, industry and government settings
• Individuals new to the field working in academic, clinical, industry and government settings

Travel Awards

SITC awarded travel reimbursement to five early career scientists who showed attendance at this program would help them reach their current and future cancer immunotherapy career objectives.

Those honored with Cancer Immunotherapy Winter School Travel Awards include:

• Vaia Florou, MD – Huntsman Cancer Center

• Sean Judge, MD – University of California, Davis 

• Uqba Khan, MD – Weill Cornell Medicine

• Abdul Rafeh Naqash, MD – National Institutes of Health, National Cancer Institute

• Aideen Ryan, PhD – National University of Ireland, Galway

2019 Cancer Immunotherapy Winter School

SITC hosted its inaugural Cancer Immunotherapy Winter School in Mesa, Ariz., Feb. 18–22, 2019.

Cancer Immunotherapy Winter School Enduring Materials

Please click on the buttons below to access enduring materials from the 2019 Cancer Immunotherapy Winter School, available for each program track.

Clinical Track

Research Track

SITC awarded travel reimbursement to five early career scientists who showed attendance at this program would help them reach their current and future cancer immunotherapy career objectives.

Those honored with Cancer Immunotherapy Winter School Travel Awards include:

• Namrata Chandhok, MD – Yale University School of Medicine; Yale Cancer Center

• Julie Collins, MD, MPH – National Institutes of Health, National Cancer Institute

• Izak Faiena, MD – University of California-Los Angeles

• Ravi Patel, PhD – University of Wisconsin-Madison

• Andy Kah Ping Tay, PhD – Stanford University

View Enduring Materials